Home › Atrial Fibrillation › Arizona › Tucson
Atrial Fibrillation clinical trials in Tucson, AZ
5 studies for Atrial Fibrillation are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Recruiting
- Tucson Medical Center Pima Heart and Vascular, Tucson
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
Recruiting
- Pima Heart and Vascular, Tucson
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- Pima Heart and Vascular, Tucson
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- Banner University Medical Center, Tucson
CardioFocus HeartLight Post-Approval Study
Recruiting
- University of Arizona Sarver HeartCenter, Tucson
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Cleveland, OH17 studies
- Boston, MA17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI11 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Austin, TX9 studies
Other studies in Tucson
- Breast Cancer20 studies
- Obesity18 studies
- Non-Small Cell Lung Cancer17 studies
- Overweight15 studies
- Metastatic Cancer14 studies
- Cancer (all types)12 studies
- Cardiovascular Disease12 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Type 2 Diabetes11 studies
- Steatotic Liver Disease10 studies
- Heart Failure10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.